Clinical Relevance of Pharmacokinetic Differences Between Beta Blockers
- 1 November 1997
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (9) , 15J-19J
- https://doi.org/10.1016/s0002-9149(97)00833-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- β-Adrenergic Blockers and Survival in Heart FailureNew England Journal of Medicine, 1996
- Exercise metabolism during 1 hour of treadmill walking while taking high and low doses of propranolol, metoprolol, or placeboClinical Cardiology, 1995
- Cardiac vagal activity: a target for intervention in heart diseaseThe Lancet, 1995
- Tolerability and Well-Being with Metoprolol in a Controlled Release (CR/ZOK) Formulation: A Review ArticleThe Journal of Clinical Pharmacology, 1990
- Is Metoprolol CR/ZOK More Selective Than Conventional Metoprolol and Atenolol?The Journal of Clinical Pharmacology, 1990
- Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY TrialJournal Of Hypertension, 1987
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967